Recent News
On October 30, 2025 the company released its September 2025 quarterly report, noting commissioning of major manufacturing equipment at the Virginia Titanium Manufacturing Campus, a 60% uplift in nameplate titanium powder capacity, and a DoW‑cofunded scale-up to 1,400 tpa with additional government obligations. On November 17, 2025 IperionX published a response to a short‑seller report, restating Department of War awards, SBIR Phase III IDIQ contract activity, and progress on the Titan Definitive Feasibility Study. On September 29, 2025 several analyst price‑target updates raised consensus targets for the company.
Technical Analysis
Directional indicators (ADX/DI+/DI-): ADX at 19.56 indicates no clear trend, while DI+ shows a peak‑and‑reversal and DI‑ shows a dip‑and‑reversal; that combination tilts near‑term directional odds toward downside pressure against the current valuation, reducing the immediacy of any breakout despite operational news.
MACD: MACD sits negative at -1.51 with a peak‑and‑reversal momentum profile, yet it recently crossed above its signal line (-1.86), producing a short‑term bullish signal that conflicts with the underlying bearish momentum; expect possible short spikes in price momentum even as broader momentum retains downward bias.
MRO: MRO registers -1.94 and shows an increasing trend, indicating price below modeled target with limited reversion potential based on the oscillator’s magnitude; that dynamic offers a technical lift risk to the downside‑constrained valuation when combined with the MACD cross.
RSI: RSI at 41.43 with a peak‑and‑reversal trend signals retreating buying strength from recent highs, supporting a near‑term consolidation bias unless buyers reassert above short‑term averages.
Price versus moving averages & EMA: Last trade at $31.76 sits below the 20‑day average ($33.80), below the 12‑day EMA ($33.46) and below the 26‑day EMA ($34.83), while near the 200‑day average ($33.31). Price below most short and intermediate averages preserves a negative short‑term price bias relative to the current WMDST valuation.
Bollinger bands & volatility: Price at $31.76 traded beneath the 1× lower band ($32.07) but above the 2× lower band ($30.34), indicating near‑band compression and potential for higher short‑term intraday volatility as bands react to any news flow; 20‑day stdev stands at $1.73 supporting muted but actionable swings.
Ichimoku and SuperTrend: Price remains below the Ichimoku cloud (Senkou A $46.24, Senkou B $48.12) and below the SuperTrend upper at $35.91, which frames the technical picture as resistant to immediate trend extension and highlights multiple overhead levels that must yield before sustained upside.
Volume and beta: Recent daily volume (97,200) sits below the 10‑day average (158,790) and 50‑day average (172,744), implying limited conviction behind the latest moves; 42‑day beta of 2.6 indicates elevated sensitivity to market swings, increasing short‑term risk on macro headlines.
Fundamental Analysis
Cash and liquidity: Cash fell from $77,126,000 at period start to $66,094,000 at period end, a decline of $11,032,000 or roughly 14.32% over the reporting period, matching the reported cashFlowDelta and reflecting cash burn tied to operations and capex.
Cash flow and capital deployment: Free cash flow registered negative $11,079,000. Capital expenditures totaled $4,562,000 while operating cash flow showed $0, producing the negative free cash flow outcome. QoQ free cash growth declined by 120.45%, while YoY free cash growth improved by 159.88%—a mixed temporal profile that signals recent quarter pressures against stronger annual momentum.
Invested capital and cost of debt: Invested capital stands at negative $72,934,820 and cost of debt approximates 2.006%, reflecting low nominal borrowing cost while invested capital figures constrain conventional return‑on‑capital comparisons.
Forward earnings and valuation metrics: Forward EPS equals $0.01125 while forward PE reads -295.71. The industry peer range shows a low of -216.66, an industry peer mean near 63.81, and an industry peer median near 91.91; IperionX’s forward PE remains well below the industry peer mean and median and sits outside the peer mean on the low end, a disparity driven by the company’s earnings profile and current price level.
Free‑cash growth versus peers: Free cash growth at -32.41% compares with an industry peer mean of approximately -174.27% and an industry peer median of approximately -215.82%, placing IperionX above the industry peer mean on this metric despite negative growth in the most recent quarter.
Other peer context: Industry peer cash conversion cycle displays a mean near -42.87 days with a wide peer range; no company cash conversion cycle provided for direct comparison.
Valuation statement: WMDST values the stock as under‑valued, driven by tangible cash reserves, government contract funding commitments, and near‑term operational scale‑up potential that the current market metrics do not fully reflect; the negative free cash flow and invested capital profile justify caution until production ramps translate into positive operating cash flow.
MOST-RECENT QUARTERLY REPORT
| REPORT PERIOD ENDING: | 2025-03-31 |
| REPORT DATE: | 2025-06-11 |
| NEXT REPORT DATE: | 2025-09-10 |
| CASH FLOW | Begin Period Cash Flow | $ 77.1 M |
| Operating Cash Flow | $ 0.00 | |
| Capital Expenditures | $ -4.56 M | |
| Change In Working Capital | — | |
| Dividends Paid | — | |
| Cash Flow Delta | $ -11.03 M | |
| End Period Cash Flow | $ 66.1 M | |
| INCOME STATEMENT | REVENUE | |
| Total Revenue | — | |
| Forward Revenue | — | |
| COSTS | ||
| Cost Of Revenue | — | |
| Depreciation | — | |
| Depreciation and Amortization | — | |
| Research and Development | — | |
| Total Operating Expenses | — | |
| PROFITABILITY | ||
| Gross Profit | — | |
| EBITDA | — | |
| EBIT | — | |
| Operating Income | — | |
| Interest Income | — | |
| Interest Expense | — | |
| Net Interest Income | — | |
| Income Before Tax | — | |
| Tax Provision | — | |
| Tax Rate | — | |
| Net Income | — | |
| Net Income From Continuing Operations | — | |
| EARNINGS | ||
| EPS Estimate | — | |
| EPS Actual | — | |
| EPS Difference | — | |
| EPS Surprise | — | |
| Forward EPS | $ 0.01 | |
| BALANCE SHEET | ASSETS | |
| Total Assets | — | |
| Intangible Assets | — | |
| Net Tangible Assets | — | |
| Total Current Assets | — | |
| Cash and Short-Term Investments | — | |
| Cash | — | |
| Net Receivables | — | |
| Inventory | — | |
| Long-Term Investments | — | |
| LIABILITIES | ||
| Accounts Payable | — | |
| Short-Term Debt | — | |
| Total Current Liabilities | — | |
| Net Debt | — | |
| Total Debt | — | |
| Total Liabilities | — | |
| EQUITY | ||
| Total Equity | — | |
| Retained Earnings | — | |
| VALUATION & PER-SHARE METRICS | EQUITY & PER-SHARE METRICS | |
| Book Value Per-Share | — | |
| Shares Outstanding | — | |
| Revenue Per-Share | — | |
| VALUATION | Market Capitalization | — |
| Enterprise Value | — | |
| Enterprise Multiple | — | |
| Enterprise Multiple QoQ | — | |
| Enterprise Multiple YoY | — | |
| Enterprise Multiple IPRWA | — | |
| EV/R | — | |
| CAPITAL STRUCTURE | ||
| Asset To Equity | — | |
| Asset To Liability | — | |
| Debt To Capital | — | |
| Debt To Assets | — | |
| Debt To Assets QoQ | — | |
| Debt To Assets YoY | — | |
| Debt To Assets IPRWA | — | |
| Debt To Equity | — | |
| Debt To Equity QoQ | — | |
| Debt To Equity YoY | — | |
| Debt To Equity IPRWA | — | |
| PRICE-BASED VALUATION | ||
| Price To Book (P/B) | — | |
| Price To Book QoQ | — | |
| Price To Book YoY | — | |
| Price To Book IPRWA | — | |
| Price To Earnings (P/E) | — | |
| Price To Earnings QoQ | — | |
| Price To Earnings YoY | — | |
| Price To Earnings IPRWA | — | |
| PE/G Ratio | — | |
| Price To Sales (P/S) | — | |
| Price To Sales QoQ | — | |
| Price To Sales YoY | — | |
| Price To Sales IPRWA | — | |
| FORWARD MULTIPLES | ||
| Forward P/E | -295.714 | |
| Forward PE/G | — | |
| Forward P/S | — | |
| EFFICIENCY | OPERATIONAL | |
| Operating Leverage | — | |
| ASSET & SALES | ||
| Asset Turnover Ratio | — | |
| Asset Turnover Ratio QoQ | — | |
| Asset Turnover Ratio YoY | — | |
| Asset Turnover Ratio IPRWA | — | |
| Receivables Turnover | — | |
| Receivables Turnover Ratio QoQ | — | |
| Receivables Turnover Ratio YoY | — | |
| Receivables Turnover Ratio IPRWA | — | |
| Inventory Turnover | — | |
| Inventory Turnover Ratio QoQ | — | |
| Inventory Turnover Ratio YoY | — | |
| Inventory Turnover Ratio IPRWA | — | |
| Days Sales Outstanding (DSO) | — | |
| CASH CYCLE | ||
| Cash Conversion Cycle Days (CCC) | — | |
| Cash Conversion Cycle Days QoQ | — | |
| Cash Conversion Cycle Days YoY | — | |
| Cash Conversion Cycle Days IPRWA | high: 352.083 median: 94.445 IPX: 0 mean: -42.867 low: -4675.718 |
|
| CAPITAL DEPLOYMENT | ||
| Cash Conversion Ratio | — | |
| CapEx To Revenue | — | |
| CapEx To Depreciation | — | |
| CAPITAL, LIQUIDITY & COVERAGE | CAPITAL STRUCTURE | |
| Total Capital | — | |
| Net Invested Capital | — | |
| Invested Capital | $ -72.93 M | |
| Net Tangible Assets | — | |
| Net Working Capital | — | |
| LIQUIDITY | ||
| Cash Ratio | — | |
| Current Ratio | — | |
| Current Ratio QoQ | — | |
| Current Ratio YoY | — | |
| Current Ratio IPRWA | — | |
| Quick Ratio | — | |
| Quick Ratio QoQ | — | |
| Quick Ratio YoY | — | |
| Quick Ratio IPRWA | — | |
| COVERAGE & LEVERAGE | ||
| Debt To EBITDA | — | |
| Cost Of Debt | 2.006 % | |
| Interest Coverage Ratio | — | |
| Interest Coverage Ratio QoQ | — | |
| Interest Coverage Ratio YoY | — | |
| Interest Coverage Ratio IPRWA | — | |
| Operating Cash Flow Ratio | — | |
| TIMING / LIQUIDITY | ||
| Days Payables Outstanding (DPO) | — | |
| DIVIDENDS | ||
| Dividend Coverage Ratio | — | |
| Dividend Payout Ratio | — | |
| Dividend Rate | — | |
| Dividend Yield | — | |
| PERFORMANCE | GROWTH | |
| Asset Growth Rate | — | |
| Revenue Growth | — | |
| Revenue Growth QoQ | — | |
| Revenue Growth YoY | — | |
| Revenue Growth IPRWA | — | |
| Earnings Growth | — | |
| Earnings Growth QoQ | — | |
| Earnings Growth YoY | — | |
| Earnings Growth IPRWA | — | |
| MARGINS | ||
| Gross Margin | — | |
| Gross Margin QoQ | — | |
| Gross Margin YoY | — | |
| Gross Margin IPRWA | — | |
| EBIT Margin | — | |
| EBIT Margin QoQ | — | |
| EBIT Margin YoY | — | |
| EBIT Margin IPRWA | — | |
| Return On Sales (ROS) | — | |
| Return On Sales QoQ | — | |
| Return On Sales YoY | — | |
| Return On Sales IPRWA | — | |
| CASH FLOW | ||
| Free Cash Flow (FCF) | $ -11.08 M | |
| Free Cash Flow Yield | — | |
| Free Cash Flow Yield QoQ | — | |
| Free Cash Flow Yield YoY | — | |
| Free Cash Flow Yield IPRWA | — | |
| Free Cash Growth | -32.407 % | |
| Free Cash Growth QoQ | -120.453 % | |
| Free Cash Growth YoY | 159.88 % | |
| Free Cash Growth IPRWA | high: 211.753 % IPX: -32.407 % mean: -174.267 % median: -215.816 % low: -329.62 % |
|
| Free Cash To Net Income | — | |
| Cash Flow Margin | — | |
| Cash Flow To Earnings | — | |
| VALUE & RETURNS | ||
| Economic Value Added | — | |
| Return On Assets (ROA) | — | |
| Return On Assets QoQ | — | |
| Return On Assets YoY | — | |
| Return On Assets IPRWA | — | |
| Return On Capital Employed (ROCE) | — | |
| Return On Equity (ROE) | — | |
| Return On Equity QoQ | — | |
| Return On Equity YoY | — | |
| Return On Equity IPRWA | — | |
| DuPont ROE | — | |
| Return On Invested Capital (ROIC) | — | |
| Return On Invested Capital QoQ | — | |
| Return On Invested Capital YoY | — | |
| Return On Invested Capital IPRWA | — | |